Literature DB >> 2562931

Increased proportion of CD4+CDw29+CD45R-UCHL-1+ lymphocytes in the cerebrospinal fluid of both multiple sclerosis patients and healthy individuals.

G Hedlund1, M Sandberg-Wollheim, H O Sjögren.   

Abstract

In this study we confirm earlier reports of an increase of the proportion of T and CD4+ lymphocytes and a decrease of B and CD8+ lymphocytes in cerebrospinal fluid (CSF) as compared to peripheral blood (PB) in MS patients. In addition we now demonstrate that this difference between CSF and PB lymphocyte populations is of the same magnitude in healthy individuals suggesting that it is physiological and not associated with disease. Functionally distinct subsets of the T human helper cell (CD4+) population have previously been defined by the monoclonal antibodies 4B4 (CDw29), Leu-18 (CD45R), and UCHL-1. In the present investigation we demonstrate a selective increase in the proportion of CD4+CDw29+CD45R-UCHL-1+ lymphocytes in CSF as compared to PB of both MS patients and healthy individuals, which strongly indicates that also this enrichment is physiological rather than associated with disease. A possible relationship between this subset of CD4+ lymphocytes and T memory cells is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2562931     DOI: 10.1016/0008-8749(89)90388-2

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

Review 1.  T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  F T Rotteveel; C J Lucas
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

Review 2.  Multiple sclerosis: a unique immunopathological syndrome of the central nervous system.

Authors:  S F Hunter; M Rodriguez
Journal:  Springer Semin Immunopathol       Date:  1995

3.  Elevation of activated gamma delta T cell receptor bearing T lymphocytes in patients with autoimmune chronic liver disease.

Authors:  L Wen; M Peakman; G Mieli-Vergani; D Vergani
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

4.  Presence of T-cell subset abnormalities in newly diagnosed cases of multiple sclerosis and relationship with short-term clinical activity.

Authors:  M Eoli; M Ferrarini; A Dufour; S Heltaj; L Bevilacqua; G Comi; V Cosi; G Filippini; V Martinelli; C Milanese
Journal:  J Neurol       Date:  1993-02       Impact factor: 4.849

Review 5.  Adaptive immune responses in CNS autoimmune disease: mechanisms and therapeutic opportunities.

Authors:  Rhoanne C McPherson; Stephen M Anderton
Journal:  J Neuroimmune Pharmacol       Date:  2013-04-09       Impact factor: 4.147

Review 6.  Mesenchymal Stem Cells Improve Rheumatoid Arthritis Progression by Controlling Memory T Cell Response.

Authors:  Noymar Luque-Campos; Rafael A Contreras-López; María Jose Paredes-Martínez; Maria Jose Torres; Sarah Bahraoui; Mingxing Wei; Francisco Espinoza; Farida Djouad; Roberto Javier Elizondo-Vega; Patricia Luz-Crawford
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

7.  Extensive Healthy Donor Age/Gender Adjustments and Propensity Score Matching Reveal Physiology of Multiple Sclerosis Through Immunophenotyping.

Authors:  Paavali A Hannikainen; Peter Kosa; Christopher Barbour; Bibiana Bielekova
Journal:  Front Neurol       Date:  2020-11-27       Impact factor: 4.003

Review 8.  Role of Immunological Memory Cells as a Therapeutic Target in Multiple Sclerosis.

Authors:  Tanima Bose
Journal:  Brain Sci       Date:  2017-11-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.